Independent minds. Global perspective. A publication for the builders
Biotechnology / New York City, NY

David van Dijk.

Founder
CellType

David van Dijk is a founder of CellType and a professor at Yale. His background includes developing biological foundation models in collaboration with researchers at Google. CellType's public materials describe combining those models with agents for drug discovery, building on research that represents cellular information for language based computational methods.

Public-source researchLast checked 1 source ↘
THE STORY, IN CONTEXT

David van Dijk and the story of CellType.

CellType's founders describe turning academic work at Yale into a company organised around biological models and agents. Their research programme seeks to make preclinical analysis more relevant to human biology. The source reports a validated research signal, which should not be conflated with an approved cancer treatment or demonstrated clinical benefit. Van Dijk's academic background establishes professional context, while the ambition to automate a full discovery pipeline remains broader than the evidence supplied in the launch.

FROM THE PUBLIC RECORD

Public advice & further reading.

No personal advice is attributed in this profile: a verifiable public advice source has not yet been established. The company and activity facts above remain separately sourced.

Suggest a first-person interview or essay ↗
EVIDENCE IN PLAIN SIGHT

Sources & attribution.

  1. 01
    CellType — Y Combinator company and active founder profile

    Public active-founder biography, current company status and description, and founding-team launch accounts. Company or team statements are attributed accounts, not independently audited performance results.

    www.ycombinator.com
About this profile

Independently researched from the public sources above. Featured people and companies are not affiliated with BusinessBlogz. Source dates and attribution provide context for the information shown; business claims remain attributed to their original source. Role and company details can change after review. The initials graphic is editorial artwork, not a photograph.

Request a correction or update ↗
KEEP EXPLORING

More builders in Biotechnology.

Explore the sector ↗